Congenital mesoblastic nephroma 50 years after its recognition: A narrative review
- PMID: 28124468
- DOI: 10.1002/pbc.26437
Congenital mesoblastic nephroma 50 years after its recognition: A narrative review
Abstract
Congenital mesoblastic nephroma (CMN) is a rare pediatric renal tumor with low malignant potential that most commonly occurs early in infancy. Treatment strategies are based on the few published CMN series, while a significant number of CMN patients have been described in case reports. The aim of this narrative review was to create an up-to-date overview of the literature. Complete surgical removal is curative in most cases. The risk of treatment-related mortality (both surgery- and chemotherapy-related) is relatively high in the first weeks of life, indicating that these young patients deserve special attention with respect to timing and type of treatment.
Keywords: clinical characteristics; congenital mesoblastic nephroma; genetics; histology; infancy; outcome; renal tumor; review; treatment.
© 2017 Wiley Periodicals, Inc.
Comment in
-
Targeting NTRK fusions for the treatment of congenital mesoblastic nephroma.Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26593. Epub 2017 Apr 25. Pediatr Blood Cancer. 2018. PMID: 28440051 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

